key: cord-0722637-wckoo603 authors: Alnajjar, Munther S.; ZainAlAbdin, Sham; Arafat, Mosab; Skaik, Sanaa; AbuRuz, Salah title: Pharmacists’ knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study date: 2022-01-12 journal: Pharm Pract (Granada) DOI: 10.18549/pharmpract.2022.1.2628 sha: 77d4d17e860f6a58aacc8db4f3b3698977758bf2 doc_id: 722637 cord_uid: wckoo603 OBJECTIVES: Internationally, pharmacists have shown a pivotal role in alleviating the unprecedented spread of the COVID-19 as they are the first touchpoint to patients. The aim of this study to evaluate the UAE pharmacists’ knowledge about and practice in the global COVID-19 pandemic. METHODS: A quantitative cross-sectional study was conducted during a period from August 2020 to January 2021. A well-designed standardized English-based questionnaire was developed based on current literature and employed for this study. FINDINGS: The results showed that 45.7% of the participated pharmacists expected to have a good level of knowledge about COVID-19 transmission, symptoms and treatment. Among the participated community pharmacists, around 25.7% educated their patients and 17.0% counseled the public about the current available therapeutic options for managing COVID-19 symptom. Most practiced activities hospital pharmacists (17.4%) was exploring new drug therapies or uses, while few hospital pharmacists (13.0%) participated in the antimicrobial stewardship programs and monitored antibiotic uses for COVID-19 cases and co-infections. Pharmacists at age ≥40 years old and have an experience of ≥10 years in the pharmacy field were more knowledgeable about COVID-19 with higher scores (p <0.001 and p= 0.001; respectively). CONCLUSIONS: The study revealed an appropriate average knowledge and practice toward COVID-19 among community and hospital pharmacists. On 30 January 2020, the World Health Organization (WHO) declared that Coronavirus disease of 2019 is the sixth public health emergency of international concern. 1 The uncontrolled growing number of COVID-19 cases is attributed to the fast human-to-human spread of a novel respiratory virus called as: "SARS-CoV-2", which results in mild to severe clinical manifestation including cough, fever, shortness of breath and/or loss of smell and taste. 2, 3 The first COVID-19 cases detected in the United Arab Emirates (UAE) were reported on 29th of January 2020, and based on latest COVID-19 updates, more than half million cases with approximately 1,610 fatalities were identified in the country. From that moment, the UAE government worked intensively to increase its preparedness at all levels to face this outbreak. It represents a unique model in response to the novel Coronavirus pandemic; as it has been implementing a set of strategies and programs against this condition. 3 One of the strategies adopted was developing the mobile pharmacy service (Dawa'ee), where medicine is delivered to patients' homes to protect patients with chronic diseases and elderly from going to hospitals and being infected in addition to reducing the pressure on medical centers. Furthermore, awareness sessions across community pharmacists were conducted to educate them about most appropriate manner to deal with such pandemics. 2, 4 However, majority of patients may experience certain medical conditions that cannot be recognized by themselves or they are unable to seek medical care at hospitals due to the increased burden on the medical staff. Therefore, pharmacists have essential contribution in alleviating the enormous strain of this COVID-19 pandemic among all healthcare providers. The community population is at higher risk for COVID-19 infection; therefore, pharmaceutical care (PC) services are among the fundamental medical services to be improved during pandemics at its all levels, especially the community pharmacies, which have opened their doors to patients even during the lockdown when other resources were limited. The main responsibilities of the community pharmacist include detecting early cases that need appropriate referral, offering over-the-counter remedies for mild symptoms and medical protective equipment as sanitizers, gloves, and face masks for proper hygiene, ensuring early and safe supply of "key medicines" beside patient's education about COVID-19, and proper counseling on minor ailments. In COVID-19, patients' symptoms are typically presented in the community pharmacy, whereby pharmacist is one of the frontline soldiers and the first point of contact, who can actively contribute to preventing the spread of COVID-19 outbreak and overall emergency management. [5] [6] [7] Hospital pharmacists amid COVID Nonetheless, it is important to highlight the pivotal role of hospital pharmacists as well, since they have effectively contributed to managing COVID-19 protocols, participating in hospital rounds alongside nurses and physicians, providing sufficient medications' supply for inpatients and ICU beds, and managing medications' shortage in collaboration with the medical team. In addition, hospital pharmacists have been involved in the antimicrobial management stewardship program; therefore, planning and participating during pathogens outbreaks as COVID-19. 8 For instance, hospital pharmacists are capable of developing protocols and recommending certain medications targeting viral and/or bacterial infections, as well as monitoring the use of antibacterial agents in case of co-infections with COVID-19. 9 As in the current situation, several empirical therapies as hydroxychloroquine, favipiravir, azithromycin, and prednisolone are used to manage COVID-19; however, none of them has been approved as an optimal treatment for COVID-19 patients. Thereby, hospital pharmacists can help researchers in assessing the efficacy and safety of the abovementioned medications' use and asking infected patients to participate in several studies and clinical research trials. 10 Being very accessible healthcare professionals, community and hospital pharmacists' role should be expanded in future pandemics as their practice is crucial in terms of reducing the load on other healthcare facilities, including the emergency department in hospitals, by clarifying misconceptions about the disease and its related medications' problems, the needed equipment for public or in ICU beds, offering tele-medicine services, and COVID-19 medication management. 11 The aims of this study are to evaluate the UAE pharmacists' knowledge about COVID-19 pandemic and to assess the pharmacists' and pharmacy work force contribution during the novel COVID-19 pandemic in the UAE. This is a quantitative cross-sectional study that was conducted during a period from August 2020 to January 2021. A well-designed questionnaire was distributed to licensed community and hospital pharmacists throughout the UAE. The questionnaire was uploaded to Google Drive and distributed online for safety and convenience. The entire survey took about 10 minutes to be completed. Trainees/intern pharmacy students or pharmacists with pharmacy practice experience of less than 3 months were excluded from the study, since their contribution in the crisis is limited compared to experienced pharmacists. The main outcomes to be measured in this study were: current knowledge and contribution (current and anticipated future practice) of the pharmacists working in either community or hospital pharmacy toward the COVID-19 crisis. In addition, the need for a mental health training program for ameliorating the stress of the pharmacists caused by this crisis. The sample size was calculated using an online sample size calculator (Raosoft) at a 95.0% confidence level and a 5.0% margin of error. 12 Based on the Federal Competitiveness and Statistics Authority (FCSA), number of pharmacists working the health sector has reached 8,469 pharmacists in 2018. 13 Therefore, the minimum required sample size for this study was 368 pharmacists. Accordingly, a convenient sample composed of 400 pharmacists was targeted to receive the survey, assuming the response rate would be ~90.0%. The research was approved by Emirates Institutional Review Board for COVID -19 Research. Participation in the study was voluntary without any consequent risk upon refusal. An online consent form attached with the questionnaire was provided to explain the purpose of the study, and all provided pharmacists' information were kept confidential and used for research purposes only. Participants were able to answer the questionnaire once they put their approval on the consent form. A well-designed standardized English-based questionnaire was produced by the authors based on current literature and employed for this study. The final version of the questionnaire highlighted the main points that illustrates pharmacists' contributions to the public health crisis of COVID-19 in the UAE. The questionnaire consists of 6 parts with a total number of 44 questions. Each question aims to evaluate pharmacists' understanding regarding a specific aspect of COVID-19. The first part of the questionnaire collects personal information required to determine the type of pharmacists answering the questionnaire (community, hospital, trainee, or academic) and the location of their workplace in the UAE. The second part includes questions that evaluate the understanding of pharmacists regarding updated information of the current pandemic, the level of their awareness and professionalism in collecting essential data concerning COVID-19 from trusted resources. Parts three and four contain questions that directly test their current knowledge about COVID-19 including: proper patients' education, ways to protect themselves and their household, COVID-19 testing, and whether there have been any discovery of treatment or vaccine. The fifth part investigates pharmacists' role and activities they can perform to combat such emergency crisis. Followed by that, the last part of the questionnaire is to assess the attitudes of pharmacists in the UAE toward introducing a healthcare care program supporting their mental health during this crisis. The face and content validity of the amended questionnaire was assessed through peer review by two relevant experts (PhD holders) with substantial experience in survey design and development. All the comments from the experts were considered when developing the final version of the questionnaire. Twenty-four questions were related to knowledge about COVID-19, correct answer for each question was given 1 point and the total score of knowledge out of 23 points was calculated by summing all correct answers. Pharmacists answered correctly at least ≥60.0% of the questions were considered at a good level of knowledge. Similarly, pharmacists working at community or hospital pharmacies who declared practicing ≥60.0% of the 14 and 8 activities; respectively, deemed to have a good practice toward the COVID-19 pandemic. Statistical analysis was carried out using the Statistical Package of Social Sciences (SPSS, version 26.0). Continues variables were reported as mean ± standard deviation (SD), while frequencies (percentages) were calculated for the categorical variables. Univariate analysis was used to compare between different groups in the mean scores of knowledge scale. P-value at <0.05 was considered significant. A total of 376 pharmacists were included in this study (mean age:33.9 ± 9.0, 50.0% males). The highest percentage of respondents were community pharmacists (37.2%, n= 140). Majority had a bachelor's degree (71.3%, n= 268), while only 22.3% (n= 84) had higher education. Although most of the pharmacists did not take online courses about COVID-19 pandemic (77.7%, n= 292), the great majority regularly check or recommend MOHAP awareness materials (81.9%, n= 308) ( Table 1 ). Figure 1 shows that 45.7% (n= 172) of the participated pharmacists expected to have a good level of knowledge. Transmission and symptoms The majority of the respondents agreed that community pharmacists should provide the public with the right preventive methods (e.g. Face mask) from COVID-19 (88.3%, n= 332) and counsel patients about COVID-19 and ways of reducing its spread and transmission (86.2%, n= 324). In addition, 84.0% (n= 316) declared that community pharmacists should seek immediate medical attention when they suspect any COVID-19 case as well as ensure the availability of key medications. Around 45.0% of the respondents disapproved that community pharmacists are unable to educate patients regarding COVID-19 due to perceived lack of time as well as that community disagreed that community pharmacists can provide medication treatment to COVID-19 patients even without a prescription (Table 4 ). More than 85.0% of the respondents have positive attitude toward hospital pharmacists including assurance of sufficient medication supply to support ICU beds, developing local treatment protocols, participating in antimicrobial stewardship programs related to COVID-19, and monitoring the use of antibiotics in cases of bacterial co-infections in COVID-19 patients (Table 5 ). Among the community pharmacists participated in this study, 25 (n= 20) provided information to the public about ways of reducing COVID-19 transmission as well as offered home delivery service during the pandemic to minimize contacts. On the other hand, the least practiced activity was providing medications for treating COVID-19 even without a prescription (5.7%, n=8) as shown in Table 4 . Results of this study indicates that one of the most One of the community pharmacists' roles is to counsel the public about COVID-19 and how to reduce its spread and transmission. 8 Community pharmacists should provide the public with the right preventive methods (e.g. Face mask) from COVID-19. 12 ( If community pharmacists suspect someone may have COVID-19, they should make sure that he seeks immediate medical attention. 16 (Table 5) . More than half of the pharmacists were concerned about the COVID-19 infection as they are part of the healthcare system and required to attend their workplace (61.7%, n= 232). Additionally, majority of the pharmacists recommended online mental healthcare training programs to support them in such emergencies (85.1%, n= 320). Regarding pharmacists' anticipated role in the COVID-19 pandemic, most of the respondents admitted that pharmacist should be considered one of the frontline healthcare workers and contributed to the vaccination (81.9%, n= 308). Moreover, exactly half of the respondents consented on engaging the pharmacists COVID-19 screening and testing (50.0%, n= 188) ( Table 6 ). respectively) compared to young-aged pharmacists or those having less than 10 years of experience. In addition, pharmacists holding higher degrees were more likely When the vaccine against COVID-19 is available, pharmacists should be considered one of the frontline healthcare workers that should be permitted to give immunizations. 28 Internationally, pharmacists have shown a pivotal role in alleviating the unprecedented spread of the COVID-19 infection and have been integrated in planning and responding to this global crisis as they are the first touchpoint to patients. Their contribution was not limited in the clinical settings, but also extended in the community to making all pharmaceutical products available, raising public awareness about COVID-19, and educating patients about effective strategies to prohibit further acquisition of the infection (such as optimal hygiene, social distancing, avoiding close contact and staying at home if having respiratory symptoms. [14] [15] [16] Up to our knowledge, the present study is the first to assess knowledge, attitude, and real practice of pharmacists across the UAE communities and hospitals during COVID-19 pandemic. Knowledge of the pharmacists is important as they serve a vital role in the COVID-19 infection control, manage drug therapies for patients and providing information related to the prescribed medications. 6, 17 Although few pharmacists (<25.0%) have taken online courses on COVID-19, the majority (>80.0%) regularly check and recommend the governmental documents related to health and prevention (MOHAP). Interestingly, majority of the pharmacists in this study were aware about general aspects of COVID-19, duration of virus incubation (average of 7; days 2-14 days), methods of infection transmission and its related symptoms. Also, most of them knew that elderly above 65 years old are at higher risk of developing COVID-19 severe illness, while some of them reported that in addition to age, patients with chronic diseases as asthma were at high risk as well. These results are consistent with previous studies conducted in Lebanon and Turkey, which reported adequate knowledge of pharmacists about general aspects of COVID-19 related symptoms, methods of transmission as well as the most vulnerable groups to develop higher risk of critical illness from COVID-19. 18, 19 Although pharmacists had an adequate knowledge about COVID-19 general information, their knowledge was moderately good concerning specific facts related to COVID-19 prevention and treatment, as the majority answered nearly 70.0% of the questions correctly. This can be related to misinformation and uncertainty of some facts related to COVID-19. Pharmacists' knowledge about preventive measures and treatment showed that few pharmacists recommended the use of NSAIDs as antipyretic agents to relieve fever which appears in 99.0% of COVID-19 cases. However, many patients with COVID-19 in reality use over the counter medications as acetaminophen or ibuprofen for alleviating their high body temperature. 20 The studies regarding this concern are conflict, some of them declared that NSAIDs may interfere with the benefit of fever in the natural body mechanism for fighting viral infections and maybe associated with increased risk of morbidity and mortality 21 while others believed that it is important to control elevated body temperature especially among children. 22 According to the the WHO, European Union's Medicines Agency and British Pharmacological Society reports, there is no consistent evidence that using NSAIDs making COVID-19 severity worse, but should be used with caution based on the consultants' recommendations. 23 Regarding corticosteroids use in COVID-19, majority of the pharmacists knew the importance of using corticosteroids in COVID-19 cases that require ventilatory support. This comes in line with previous study that showed lower mortality rates and shorter duration of staying in the hospital among hospitalized COVID-19 cases with lung dysfunctions who received low doses of corticosteroids. 24 In the current study, less than half of the pharmacists recognized that hydroxychloroquine is not a key preventive agent against COVID-19 and should be used with caution to treat certain cases. Results from previous RCT (PATCH trial) did not report any preventive benefit of hydroxychloroquine among healthcare providers that are frequently exposed to the infection. 25 In addition, majority of pharmacists believed that combination of hydroxychloroquine and azithromycin potentially treats COVID -19.This claim can be supported by previous study that reported benefit of using hydroxychloroquine in viral elimination especially when it is combined with azithromycin, 26 on the other hand, recent reports by the American College of Cardiology, American Heart Association, and the Heart Rhythm Society suggested QT assessment and monitoring when both medications are used as some researchers reported risk of QT prolongation when these drugs are co-administered. 25, 27 In this study, most of the pharmacists believed that vitamins C and D are essential for improving patients' immunity system and regular exercising also enhances the ability of white blood cells to fight the infection. According to the available data, vitamin C or vitamin D deficiency compromises the immunity function making the body more vulnerable to get infected, thereby, adequate supplementation of these vitamins is a promising therapeutic approach to fight COVID-19. 28 Furthermore, countless studies proved that sedentary life-style contributes to chronic metabolic problems, however, regular physical exercising elicits a cascade of mechanisms in the body that ultimately boosts the immunity system. 29 Moreover, most of the pharmacists in this study recognized the groups of patients eligible for COVID-19 testing as reported by the WHO guidance on COVID-19 including hospitalized patients, elderly above 65 years old with symptoms and healthcare facility workers with symptoms. 30 Consistent with previous study, the current study revealed that age (≥40 years old), higher education, working at the hospital pharmacy, and having experience of ≥10 years were the main contributing factors of better knowledge about Attitude Concerning the attitude of pharmacists, majority of them had positive attitudes toward struggling the COVID-19 crisis most probably due to devoted efforts and regulations of the UAE healthcare system against this crisis. Majority of pharmacists stated that it is the community pharmacist's responsibility to provide public with right preventive methods (as Face mask and proper hygiene) from COVID-19 as well as counseling about ways of minimizing the spread and transmission of the virus. This finding agrees with several previous studies, which indicated the crucial role of community pharmacists in counseling patients about COVID-19 and raising public awareness about the precautionary and preventive measures as safe hygiene practice to minimize transmission rate of the infection. 31, 32 In addition, respondents agreed that community pharmacist should seek medical attention of COVID-19 suspected cases and ensure availability of key medications to treat mild cases confidently. Similarly, a previous study in Jordan supported this attitude as community pharmacists can triage their patients to appropriate healthcare management. 33 Despite that, only 45.0% of the pharmacists disapproved the claim that community pharmacists are unable to educate patients regarding COVID-19 due to perceived lack of time and disagreed that community pharmacists can provide medication treatment to COVID-19 patients even without a prescription. This urges the need of improving pharmacists' knowledge and expanding their responsibilities to acquire more clinical services the benefit the patients in this pandemic. Besides, AlMazrouei et al. (2020) emphasizes the importance of continues education programs and training for the community pharmacists in the UAE to be engaged in COVID-19 screening, prevention and emergency patientcentered care. 31 On the other hand, pharmacists in general showed more trust in hospital pharmacists during COVID-19 pandemic. More than 85.0% of the participated pharmacists in this study believed that hospital pharmacists can be more involved in the clinical responsibilities during this pandemic including assurance of sufficient medication supply to support ICU beds, developing local treatment protocols, participating in antimicrobial stewardship programs related to COVID-19, and monitoring the use of antibiotics in cases of bacterial co-infections in COVID-19 patients. This positive attitude toward major clinical services conducted by the hospital pharmacists is attributed to the direct involvement of hospital pharmacists in planning and responding to the pathogens, developing potential treatment approaches for diseases, and assisting in conducting research on infected patients. 8 Community pharmacies in the UAE are well-equipped with variety of pharmaceutical products, which assist pharmacists in selecting between several alternatives depending on availability and patients' preferences. However, the pharmaceutical market is susceptible to shortage, which leads to risk of medications errors or patients' dissatisfaction. Based on documented data in the literature, community pharmacists in the UAE are well-positioned to educate patients and assure them of continues availability of over the counter and prescription medications to be used in certain minor ailments based on rational levels of demands. 31, 34 Regarding pharmacists' practice against COVID-19 pandemic, 25.7% of the community pharmacists in the present study educated their patients and 17.1% counseled them about the currently available therapeutic options for alleviating COVID-19symptoms.While other community pharmacists' activities were practiced to even less extent (around 11.0%) such as counselling about ways of disease's transmission, offering home delivery services to minimize contact, screening, diagnosis, or treatment of minor COVID-19 cases. On the other hand, previous studies conducted in the UAE reported that UAE community pharmacists are well-prepared to encounter the spread of the infection and raise awareness. However, that study is limited to general assessment of knowledge and preparedness rather than real practice. 31 Hospital pharmacists' practice was also assessed in this study, and the results indicated that the most practiced clinical activity toward the COVID-19 was exploring new drug therapies or uses for reducing the severity and complications of the disease. Also, some hospital pharmacists participated in the antimicrobial stewardship programs and monitored antibiotic uses for COVID-19 cases and co-infections (13.0%). While the least practiced activity was contribution to the protocol management of COVID-19.Along the same line, the American Society of Hospital Pharmacists (ASHP) stated that hospital pharmacists are responsible for encouraging immunization and screening for certain infectious diseases as well as collaborating with other healthcare providers in establishing guidelines for risk assessment, therapy management, and monitoring patients' health outcomes in case of transmissible infectious diseases. 35 In addition, the WHO has issued a checklist material for assessing the readiness and ability of healthcare workers to enhance their response to COVID-19. 36 However, our findings revealed that pharmacists in the UAE working at either community or hospitals has not yet evolved to be incorporated in in multidisciplinary areas to alleviate the burden on the healthcare system. Thereby, it is crucial to protrude pharmacists' responsibilities and train them to confront the COVID-19 pandemic effectively. Several studies were parallel with our findings that pharmacists were frustrated and harassed during COVID-19 pandemic as they were required to attend their work place to assist public in managing their minor ailments, making medications for chronic diseases available, and raise public awareness regarding basic hygiene tips to protect themselves from the infection. 37, 38 For that reason, majority of the surveyed pharmacists suggested online mental healthcare training programs to support them in such emergencies. In the present study, most of the pharmacists admitted the value of pharmacists' contribution in COVID-19 as frontline healthcare workers. Moreover, they promoted combining pharmacists' traditional responsibilities with COVID-19 vaccination and screening services to be part of their job. And on the same approach, the ASHP has issued an executive summary recommending authorization of proper immunization (vaccination), specimen collection, and test results interpretation by pharmacists. 39 In conclusion, the proposed study revealed an appropriate average knowledge and practice toward COVID-19 among pharmacists in the UAE. In addition, the study demonstrated that years of experience and higher level of education were significant determinants of better knowledge about the COVID-19 pandemic control. Hospital and community pharmacists' knowledge about COVID-19 were almost similar regardless the differences in work place. None. This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. The datasets generated during the current study are available from the corresponding author on reasonable request. Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study. Pharmacy Practice Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study. Pharmacy Practice Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study. Pharmacy Practice Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study. Pharmacy Practice Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study. Pharmacy Practice The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just Begun Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence Information Center UAE: Ministry of Health and Prevention Model in Confronting Coronavirus Pandemic UAE: Emirates Policy Center Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective COVID-19: Testing information: CVS health Journal of pharmaceutical policy and practice Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck Amer Am R. SARS-CoV-2 outbreak: How can pharmacists help? Research in social & administrative pharmacy : RSAP Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond Sample size calculator Population and Demography, Health, Pharmacists UAE: Federal Competitiveness and Statistics Authority Improving pharmacist involvement in pandemic influenza planning and response in Australia Australian Healthcare and Hospital Association COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic Pharmacists at the frontline beating the COVID-19 pandemic Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study Knowledge and Attitudes Among Hospital Pharmacists About COVID-19. Turkish journal of pharmaceutical sciences Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Antipyretic drugs in patients with fever and infection: literature review Antipyretic efficacy of ibuprofen vs acetaminophen WHO clarifies guidance on ibuprofen, says there's no evidence it can worsen COVID-19: Canadian Broadcasting Corporation (CBC) On the use of corticosteroids for 2019-nCoV pneumonia What is the role of hydroxychloroquine plus azithromycin in the treatment of coronavirus disease 2019 (COVID-19)?: Medscape Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Pharmacists' knowledge, attitude and practice in the UAE toward the public health crisis of COVID-19: A cross-sectional study Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity. Frontiers in nutrition The immune-modulatory effects of exercise should be favorably harnessed against COVID-19 Guidance on COVID-19 for the care of older people and people living in long-term care facilities, other non-acute care facilities and home care: World Health Organization The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. The International journal of pharmacy practice Community pharmacists and communication in the time of COVID-19: Applying the health belief model Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles Drug shortages: a complex health care crisis Hospital readiness checklist for COVID-19 Mental health issues impacting pharmacists during COVID-19 The burden of COVID-19 on pharmacists PHARMACISTS AS FRONT-LINE RESPONDERS FOR COVID-19 PATIENT CARE: Executive Summary: American Society of Hospital Pharmacists This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. The authors declare no competing interests.